M. J. Duffy
Publications by Year
Research Areas
Protease and Inhibitor Mechanisms, Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, Cardiac, Anesthesia and Surgical Outcomes, Peptidase Inhibition and Analysis
Most-Cited Works
- → Clinical Uses of Tumor Markers: A Critical Review(2001)159 cited
- → Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1(2006)158 cited
- → Serum tumour markers: how to order and interpret them(2009)111 cited
- → Smoking habits of long-term survivors of surgery for lung cancer.(1982)65 cited
- Urokinase-type plasminogen activator in colorectal cancer: relationship with clinicopathological features and patient outcome.(1997)
- → Cathepsin D concentration in breast cancer cytosols: correlation with biochemical, histological, and clinical findings(1991)54 cited
- → Levels of specific glycans significantly distinguish lymph node-positive from lymph node-negative breast cancer patients(2010)43 cited
- → Cathepsin D Concentration in Breast Cancer Cytosols: Correlation with Disease-Free Interval and Overall Survival(1992)34 cited
- → Tissue-Type Plasminogen Activator in Breast Cancer: Relationship With Estradiol and Progesterone Receptors(1986)31 cited
- → Enzyme-Linked Immunosorbent Assay of C-Erbb-2 Oncoprotein in Breast Cancer(1992)22 cited